chrisvoncsefalvay/vaers-outcomes huggingface dataset:
experiencing side effects from the Moderna vaccine; A spontaneous report was received from a consumer concerning a patient (age and gender unspecified) who received Moderna's Covid-19 vaccine (mRNA-1273) and was experiencing side effects from the Moderna vaccine.  The patient's medical history was not provided. Concomitant product use was not provided.  On 23 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot number: not provided) through an unknown route in an unknown arm , for prophylaxis of COVID-19 infection.   On an unspecified date, the patient was experiencing side effects after receiving the Moderna COVID-19 Vaccine.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   Outcome of the event of experiencing side effects from the Moderna vaccine was unknown.; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Dec 2, 2022: nausea, chills, sore throat, headache  Dec 13, 2022: runny nose, chills, body aches, fatigue, cough
From initial information received on 7/28/04 from a physician regarding an adverse event occurring in the USA, it was reported that a 47 year old female patient received a dose of TD ADS ADULT, lot number not reported, administered IM in the right arm on 6/26/04. Six to eight hours after immunization, the patient developed pain in her right arm, which progressed to her right shoulder. The patient was seen in the office on 7/28/04. At the time of the report, her recovery status was unknown.
Spots of swelling in the walls of the mouth, locations changing over a 24 hour period. Moved from left side to right side. Soothed with baking soda rinse. No problems with breathing nor throat swelling.
no adverse effects; two patients, received improperly stored PROQUAD; This spontaneous report as received from a medical assistant and refers to a patient of unknown age.  The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.      On 28-MAY-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), for prophylaxis lot number R030800 and expirtation date 22-APR-2019 (dosage schedule, route, anatomical location, lot number and expiration date were not reported). The administered dose of the vaccine experienced a temperature excursion of 15 degrees Fahrenheit to 46 degrees Fahrenheit. Total frame from 15-MAY-2019 to 31-MAY-2019 (16 days, 384 hours).  No previous temperature excursion. It was not recorded by a data logger.; Sender's Comments:  US-009507513- 1906USA000953:
Patient presents to the Vaccine Healthcare Center today with questions regarding vaccinations received around the time she became pregnant.  She reports that she is approximately 22 weeks pregnant and that her delivery date is 20 Jan 2004.  She is unsure of when her last menstrual period was but thinks it was mid-March to Mid-February.  She reports no problems with this pregnancy but is concerned because she received several vaccines (Yellow Fever, Tetanus Diphtheria, Hep A #2, Heb B #1, PPD)  before she knew she was pregnant.  She had an ultrasound on 11 Sep 2003 that was normal and estimated her to have an EDC of 18 January 2004.
Shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 63-year-old female patient who received Herpes zoster (Shingrix) (batch number AP257, expiry date 26th November 2021) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional case details were reported as follows: The reporter was filing in at the pharmacy and had no additional information on the topic including address. The reporter did not consent to follow up.
Information has been received from a nurse concerning a 9 year old female with no medical history or allergies who on 24-APR-2007 was vaccinated SC in left arm with 0.5 ml dose of Varivax (lot # 656688/0124U). There were no concomitant medications. On 24-APR-2007 the patient developed swelling at injection site. On the evening of 25-APR-2007 the patient's symptoms worsened. The patient developed 2 x 3 inch erythematous, warm, slightly tender, clearly demarcated inflammation reaction at injection site on left arm and had body temperature of 99.2 F. The patient was prescribed ice on the left arm at the site of redness for 10 minutes three times a day for 2-3 days. The patient was also prescribed ibuprofen 300 mg by mouth three times a day for 2.3 days. No diagnostic laboratory tests were performed. A product quality complaint was not involved. The 2 x 3 inch erythematous, warm, slightly tender demarcated inflammation reaction was considered to be other important medical events by the reporter. Additional information has been requested.
Pt was seated in observation area after vaccine administration. She started to get dizzy and walked up to pharmacy counter and fainted/passed out. She fell and hit her head on the ground.  She had a gash on her forehead, so we called 911 and had paramedics notified. Fire  Department arrived and assessed her. BP and HR wnl, bleeding under control, no further medical attention needed. Pt was feeling better, and was able to stand up.  Pt was able to go home, no  hospital necessary. I contacted her later that evening and she was feeling better, no further adverse effects.
Left nostril and face rash, hard to swallow became severe after Easter weekend. Patient claimed being diagnosed with shingles and was hospitalized.
arm of injection with pimples; arm of injection itchy; arm of injection burning rash; sore arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of RASH PAPULAR (arm of injection with pimples), VACCINATION SITE PRURITUS (arm of injection itchy), VACCINATION SITE PAIN (sore arm of injection) and VACCINATION SITE RASH (arm of injection burning rash) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm of injection). On 27-Jan-2021, the patient experienced RASH PAPULAR (arm of injection with pimples), VACCINATION SITE PRURITUS (arm of injection itchy) and VACCINATION SITE RASH (arm of injection burning rash). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 22-Jan-2021, VACCINATION SITE PAIN (sore arm of injection) had resolved. At the time of the report, RASH PAPULAR (arm of injection with pimples), VACCINATION SITE PRURITUS (arm of injection itchy) and VACCINATION SITE RASH (arm of injection burning rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided
Throat closed up; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient (Reporter's sister) that: A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as single dose and dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Caller reported that her sister (patient) who was vaccinated having the same side effects. Caller reported that the patient's throat closed up on unspecified date and the patient is having all kinds of troubles. Caller declined to complete safety report for the patient. Caller reported that she would tell the patient to call Pfizer to file a report. Caller reported that she had just heard through her mom that the patient had reactions to both doses of the Covid-19 vaccine and had to be monitored. Caller reported that her mother informed the caller that the patient's throat closed up. Caller reported that she would have the patient call to make a report as the caller would be unable to provide many details of the patient's experience. The outcome of the event was reported as unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021 at 1:52 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 28-Mar-2021 at 1:46 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 28-Feb-2021 at 1:52 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 25.71 for dose administered on 28-Feb-2021 and 25.79 for dose administered on 28-Mar-2021.  No concomitant medications were reported.  Vial was moved to fridge on 24-Feb-2021. Product moved to clinic on 27-Feb-2021. Batch number 014M20A underwent temperature excursion on 28-Feb-2021 with temperature 27 degrees Fahrenheit at 09:00 AM and 26 degrees Fahrenheit at 01:00 PM. Beyond use date for the vial was reported as 26-Mar-2021.   Vial was moved to fridge on 23-Mar-2021. Product moved to clinic on 27-Mar-2021. Batch number 019B21A underwent temperature excursion on 28-Mar-2021 with temperature 35 degrees Fahrenheit from 10:00 AM. Beyond use date for the vial was reported as 22-Apr-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
I also had a seizure like episodecat night where I nearly bit my tongue off; 3 minutes after I had an altered mental experience, also twice in the war home. I have since had one a week but they are increasing in frequency I had four yesterday; I also experience some memory loss and sometimes am very emotional or have a headache aftwrwards; I also experience some memory loss and sometimes am very emotional or have a headache aftwrwards; I also experience some memory loss and sometimes am very emotional or have a headache aftwrwards; I have itinerant chest pain in addition; This is a spontaneous report from a contactable consumer (reporting for herself). A 50 year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: En9581), via an unspecified route of administration on 28Jan2021 at 09:15 (at the age of 51-year-old), as dose 1, single in right arm and received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EI9826), via an unspecified route of administration on 17Feb2021 at 09:00 (at the age of 51-year-old), as dose 2, single in right arm for COVID-19 immunization. The patient's medical history included nine. Concomitant medications within 2 weeks of vaccination included vitamin D NOS (VITAMIN D), taken for an unspecified indication, start and stop date were not reported. The patient previously took penicillin and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Jan2021, at 09:15 AM, the patient experienced seizure like episode cat night where she nearly bit her tongue off. 3 minutes after she had an altered mental experience, also twice in the war home. Patient had one a week, but they were increasing in frequency she had four in the previous day. Patient visited the emergency room and neurologist after that. The patient also experienced some memory loss and sometimes was very emotional or had a headache afterwards. Patient had itinerant chest pain in addition. Treatment received for the events included EEG (Electroencephalogram) upon neurology visit. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The clinical outcome of all the events was reported as not resolved.
Black stools, then had 2nd vaccine in February, dizzy spells that got progressively worse, shortness of breath, hospitalized twice in March. Diagnosed with pulmonary embolism  in left lung.
VACCINE WAS ACCIDENTLY PROVIDE TO UDNER 18 YEARS OF AGE PATIENT.  PT WAS ADVISED TO STAY AT THE PHARMACY FOR 20 MINUTES TO MONITOR FOR ADVERSE EFFECT(S). NO ADVERSE SYMPTOMS  WAS NOTICED
Received vaccines (3), 2 on right deltoid and 1 on left deltoid at 09:00 on 5/13/02. On 5/15/02 AM, red and painful right deltoid. No fever and full ROM.
On 14NOV91, pt recvd flu vax & devel fever of 100 on 15NOV91; also site of immun red & swollen; pts MD stated pt was very sensitive to get only 1/2 shot next time;
Information has been received from a physician concerning a female who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck) (lot number not reported). There was no concomitant medication. The physician reported that the patient came down with a light case of the shingles about three months after she had the ZOSTAVAX (Merck) shot and they now considered her a non-responder. The patient sought unspecified medical attention. The patient was treated with acyclovir (manufacturer unknown). Upon the time of the report, the patient's present status was unknown. The patient's a light case of the shingles and they considered her a non-responder were considered to be an other important medical event by the physician. Additional information has been requested.
Burning and raw sensation around right armpit and behind armpit including a feeling a needles pricking from time to time into the armpit
I am in the middle of an illness where I an have wheezing, nasal congestion and fever I tested but it was negative for COVID- 19. I went to the clinic 2 times, they gave me antibiotic. I am still feeling sick and haven't gotten better.
Slight headache; Strong muscle; Strong joint pain; gassiness; Soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of FLATULENCE (gassiness), VACCINATION SITE PAIN (Soreness at injection site), HEADACHE (Slight headache), MYALGIA (Strong muscle) and ARTHRALGIA (Strong joint pain) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced FLATULENCE (gassiness) and VACCINATION SITE PAIN (Soreness at injection site). On 06-Feb-2021, the patient experienced HEADACHE (Slight headache), MYALGIA (Strong muscle) and ARTHRALGIA (Strong joint pain). On 08-Feb-2021, FLATULENCE (gassiness), VACCINATION SITE PAIN (Soreness at injection site), HEADACHE (Slight headache), MYALGIA (Strong muscle) and ARTHRALGIA (Strong joint pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided. No relevant concomitant medications reported.
pain in her thighs like muscle aches and then nausea and then bad swelling in her right axialla same arm of shot and had mammogram scheduled today and they could not do it with the swelling and pain
Myalgia, Arthralgia, Fever, weakness, fatigue Narrative:  One the evening of the day she received the vaccine, the patient reported a fever (temp unknown), weakness in the arm she received the injection, body aches and fatigue. These symptoms persisted through the next day.
First night I was up all night from the pain in my arm. I also had neck pain,  and the base of my neck was swollen. Day two was the worse of the swelling and pain. I believe it is swollen lymphs nodes in my neck.    I took my temperature on day two, it was 98.8. However I was tired and cold chills,, all day on day two and slept for 2 or 3 hours. Today is day three and I feel pretty normal. The swelling has gone down but still there and tender to the touch. No fever or cold chills..
First dose: slight discomfort in arm 6hrs after injection. Then deep pain in the arm 9 pm. Some chills at night. Took Motrin and pain in arm gone fairly quickly and chills gone immediately   Second dose after...: 3hrs  slight discomfort in arm 9hrs deep pain in arm but never as bad as first dose 12 hours 99.7F 13 hrs 100F 18hrs 100.4F 22hrs 101.4F And then decrease in temp throughout the day and stayed constant for 48hrs at 99F Chills, sensitive skin, really bad head aches starting 26hrs after injection and proceeding for 48hrs (mild on last 12 hrs) Motrin was taken
Patient reported pain, redness, fever, malaise, edema. Needed to view camera to verify which arm received vaccine patient received shingrix in right deltoid and pneumovax 23 / fluad in left deltoid
Moderna COVID -19 Vaccine EUA. Rash on arms on & off the past week. Itching from rash.  Right upper arm petechia noted today. Will try to get appt 1/20 to see my PCP and get CBC with diff & platelets
Information has been received from a medical assistant concerning multiple unspecified patients of unknown age and gender. The patients' concurrent conditions, medical histories and concomitant therapies were not reported. On unknown dates in October 2016 (reported as "at the beginning of October 2016"), the patients were vaccinated with doses of improperly stored VARIVAX (lot # L046887 with expiration date 03-NOV-2017, lot # M025867 with expiration date 24-MAY-2018, lot # M024680 with expiration date 18-MAY-2018; dose and route were unknown). The vaccines were exposed under temperature of 14 degrees Fahrenheit for a short amount. The previous temperature excursions started at the beginning of October 2016. Data Logger was involved. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Patient presented on 10/24/2007 to ER 8 days post vaccination series as listed in #13.  Per ER report he noted approx 4 days previously (20 Oct) to have began experiencing redness and swelling in L-deltoid vaccination site, along with vague malaise and achiness.  Day prior to ER presentation he noted obvious enlarging redness and small ulceration.  Additional symptoms included chills.  Upon ER presentation it was noted that he was afebrile but had elevated WBC (11.4)--he was treated with IV ABX (Unasyn 3 gm), Toradol for his achiness, and sent home for ER follow-up in am.  He returned the next day with reported high fever, aching, chills, and per his wife weak, shortness of breath, confused during night. T-101, P-120, R-18 BP 140/87.  ER doctor felt he was toxic appearing upon this presentation.  Other clinical findings include diaphoretic, mild-moderate ill appearing, erythematous tonsillar pillars with positive exudate, shoddy anterior adenopathy, L-supraclavicular adenopahty, L-deltoid 10 X 8 cm erythema that surrounds a 1 cm ulcerated area with lymphangitis extending to shoulder, marked L-axillary adenopathy.  Patient was then transferred to Medical Center for inpatient care and further evaluation.  Upon arrival patient was stable, non-toxic appearing with vitals: T-97.5, R-18, P-86,  BP-139/86 P/O-100% RA.  L-deltoid erythema noted to be 9cm X 8cm with 1cm ulceration at vaccination site with lymphangitis extending superiorly onto shoulder.  Adenopathy was noted bilaterally shoddy anterior cervical, L-supraclavicular, and moderate L-axillary.  Bilateral tonsillar pillars noted to be erythematous, no exudates, no petichia noted.  Marked improvement in symptoms by hospital day 1 noted (post vaccine day 10).  Upon admission patient was placed on Contact Isolation, IV fluids for hydration secondary to increased creatinine until it normalized, IV AB-Unasyn continued until results returned coag neg staph (wound culture), and blood cultures negative.  An ECHO was perfomed and consultation was obtained with Cardiology immediatly upon patient arrival given elevated troponin--diagnosis was given for myopericarditis (mild) secondary to small pox vaccination given elevated troponin.  Patient was treated with 7 days of Ibuprofen 600mg every 6 hours.  Contact was made with Health Center  and recommendations for myopericarditis protocol initiated to include cardiology follow-up.  Patient was discharged on HD #3 when troponin was trended down and under the normal range as per protocol.  During presentation and hospitatlization denied any symptoms of chest pain/discomfort, no shortness of breath or difficulty breathing.  Planned follow-up includes Hospital follow up in 1 week, Cardiology follow-up in 4 weeks, follow-up Medical Center or Medical Center-- Health Care Center.
This spontaneous report was received from a physician via an online article, referring to a female patient of unknown age. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On an unknown date, the patient was vaccinated with GARDASIL (route, dose, frequency, anatomical location, lot # and expiration date were unknown) for prophylaxis. The article reported that the girl's life was destroyed after she was vaccinated with the GARDASIL, leading her to commit suicide. The reported did not mention the causality assessment between the events of suicide and quality of life decreased with GARDASIL. Upon internal review, suicide was determined to be medically significant. This is one of two cases from the same reporter. Sender's Comments: US-009507513-1710USA005030.